The DEAH-box family of RNA-dependent NTPases (DHX) plays a crucial role in RNA metabolism, including processes such as splicing, ribosome biogenesis, and mRNA export from the nucleus. These proteins act as molecular motors that harness the energy from nucleotide hydrolysis to unwind or remodel RNA and RNA-protein complexes. The DHX proteins generally contain conserved motifs that are essential for ATP binding and hydrolysis, as well as RNA binding and unwinding. Through their ATPase and helicase activities, DHX proteins are able to dynamically regulate the structure and function of various RNA molecules and complexes, thereby influencing diverse cellular processes.
The class of molecules known as DEAH-box RNA-dependent NTPase (DHX) Inhibitors is specifically designed to modulate the activity of the DHX family of proteins, which are central to RNA metabolism in the cell. These inhibitors typically target the ATPase or helicase domains of DHX proteins, as these are the functional cores responsible for nucleotide binding, hydrolysis, and the subsequent RNA remodeling activities. Some inhibitors may act by binding directly to the ATPase pocket, thereby ATP from binding and disabling the enzyme's activity. Others may bind to regions of the protein that are essential for RNA interaction, therefore making the protein unable to engage with its natural RNA substrates. Some inhibitors are allosteric in nature and can bind to regions other than the active site, causing conformational changes that make the enzyme less effective or completely inactive.
VER TAMBIÉN ....
Items 1 to 10 of 11 total
Mostrar:
| Nombre del producto | NÚMERO DE CAS # | Número de catálogo | Cantidad | Precio | MENCIONES | Clasificación |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | ¥745.00 ¥2471.00 ¥4705.00 | 97 | |
Inhibidor de PI3K que afecta a las vías posteriores de procesamiento del ARN. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | ¥451.00 ¥925.00 ¥2888.00 | 127 | |
Inhibe la síntesis de proteínas, afectando indirectamente al procesamiento del ARN. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | ¥903.00 ¥2392.00 ¥4603.00 | 48 | |
Inhibe JNK, que desempeña un papel en el empalme de ARN. | ||||||
Akt Inhibitor IV | 681281-88-9 | sc-203809 sc-203809A | 5 mg 25 mg | ¥1952.00 ¥7841.00 | 42 | |
Inhibe Akt, que interviene en el procesamiento del ARN. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | ¥301.00 ¥1128.00 | 257 | |
Inhibidor de JNK que puede afectar al empalme del ARN. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | ¥857.00 ¥2437.00 | 101 | |
Influye en la función de las helicasas de ARN como DDX38 causando daños en el ADN. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | ¥406.00 ¥1681.00 | 11 | |
Interfiere indirectamente en la actividad de la ARN helicasa al alterar el metabolismo de los nucleótidos. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | ¥361.00 ¥1918.00 ¥4344.00 | 63 | |
Inhibidor de la topoisomerasa II que puede afectar al procesamiento del ARN. | ||||||
2′-Deoxy-2′,2′-difluorocytidine | 95058-81-4 | sc-275523 sc-275523A | 1 g 5 g | ¥632.00 ¥1444.00 | ||
Interfiere en la síntesis y reparación del ADN, afectando a las helicasas de ARN como DDX38. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | ¥643.00 ¥2053.00 ¥1038.00 | 21 | |
Inhibidor de la topoisomerasa I que provoca daños en el ADN que afectan a las helicasas de ARN como DDX38. | ||||||